Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ADMA Biologics Inc logo

ADMA Biologics Inc

Sector: Healthcare   

Industry: Biotechnology

10.63
 
USD
  
-0.15
  
(-1.39%)
Optionable: Yes  Market Cap: 2,434 M  90-day average vol: 2,743,050

Previous close: 10.78  Open: 10.67  Bid: 10.54  Ask: 10.8
52 week range    
3.06   
   10.86
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ADMA Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AllowancesForConstruction80 M
Amortization of intangibles1 M844938.0844938.0715353.0715353.0700000.0700000.0
Basic EPS from continuing operations-0.88-0.51-0.33-0.13
Basic EPS total-1.17-0.88-0.51-0.33-0.13
Basic weighted shares outstanding9 M10 M12 M23 M45 M54 M86 M140 M198 M224 M
Cost of sales-4 M-4 M-6 M-29 M-42 M40 M61 M80 M119 M169 M
Depreciation-247852.0-469821.0-400000.0-3 M-3 M-3 M-4 M5 M7 M8 M
Depreciation unreconciled-247852.0-469821.0-469576.01 M844938.0844938.0715353.0715353.0700000.0700000.0
DepreciationAndAmortization-247852.0-469821.0-469576.01 M844938.0844938.0715353.0715353.0700000.0700000.0
DevelopmentExpense169 M
Diluted EPS total-1.81-1.73-1.61-1.91-1.45-0.89-0.88-0.51-0.33-0.13
Diluted normalized net income/share-0.89-0.88-0.51-0.33-0.13
Diluted weighted shares outstanding9 M10 M12 M23 M45 M54 M86 M140 M198 M224 M
GainOnSaleOfPPE207071.081697.0
GainOnSaleOfSecurity-74356.067860.0
GeneralAndAdministrativeExpense5 M7 M8 M19 M23 M26 M-700000.043 M52 M59 M
Gross operating profit2 M3 M4 M-6 M-25 M-10 M-19 M1 M35 M89 M
ImpairmentOfCapitalAssets845389.0
Income before tax-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M-28 M
Income restructuring and M&A83 M53 M119 M
Income taxes-551724.0-602391.0-1 M-17 M-104430.0-474229.0-416312.0-251839.0-2 M-763000.0
Interest income14217.037830.050317.057228.0195403.012 M288126.034532.045000.02 M
InterestExpenseNonOperating1 M2 M2 M3 M6 M9 M12 M93 M19 M25 M
InterestExpenseOperating-2 M-2 M-4 M-10 M-10 M-11 M-14 M-18 M
MarketingExpense-200000.0-600000.0-800000.0-1000000.0-1 M1 M2 M3 M
MiscOtherSpecialCharges74356.0-719097.04496.0-1 M-127121.0-10 M863269.0-251575.0-7 M-26 M
Net income from total operations-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M-28 M
NetIncomeCommonStockholders-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M-28 M
NetIncomeContinuousOperations-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M-28 M
NetNonOperatingInterestIncomeExpense-1 M-2 M-2 M-3 M-5 M3 M-12 M-93 M-19 M-23 M
Normalized income-25 M
Operating income-16 M-16 M-17 M-38 M-60 M-41 M-65 M-58 M-39 M22 M
Operating income before depreciation (EBITDA)-16 M-15 M-18 M-39 M-60 M-45 M-68 M17 M-51 M-10 M
OperatingExpense-22 M-23 M-28 M-62 M-77 M31 M46 M60 M75 M67 M
Other income net74356.0651237.0-4496.01 M127121.010 M-863269.0251575.07 M26 M
Other special charges3 M4 M
OtherGandA5 M7 M8 M19 M23 M26 M-700000.043 M52 M59 M
OtherOperatingExpenses4 M5 M5 M7 M8 M2 M4 M12 M18 M4 M
RentAndLandingFees5 M7 M8 M19 M23 M-600000.0-700000.0
Research & development expense10 M7 M8 M6 M4 M2 M6 M4 M4 M173 M
ResearchExpense10 M7 M8 M6 M4 M2 M6 M4 M4 M3 M
RestructringAndMnAIncome83 M53 M119 M
Revenue per share1 M844938.0844938.0715353.0715353.0700000.0700000.0
SalariesAndWages-1 M-2 M-1 M-2 M-2 M-3 M-3 M3 M5 M6 M
Selling Gen & administrative expense5 M7 M8 M19 M23 M26 M35 M43 M52 M59 M
SellingAndMarketingExpense-200000.0-600000.0-800000.0-1000000.035 M1 M2 M3 M
SellingExpense35 M
Special income/charges-83 M-845389.0-119 M-4 M
Total Income available for interest expense (EBIT)-16 M-16 M-19 M-43 M-65 M-50 M-74 M10 M-60 M-21 M
Total common shares outstanding9 M11 M13 M45 M46 M86 M121 M196 M222 M228 M
Total net income-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M-28 M
Total ordinary shares232 M232 M232 M232 M232 M232 M232 M232 M232 M232 M
Total revenues6 M7 M11 M23 M17 M29 M42 M81 M154 M258 M
TotalExpenses-26 M-27 M-34 M-91 M-119 M71 M107 M139 M193 M237 M
TotalRevenue6 M7 M11 M23 M17 M29 M42 M81 M154 M258 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University